HOTH - Hoth Therapeutics, Inc.
0.8955
-0.028 -3.071%
Share volume: 60,076
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.92
-0.03
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-14-2024 | 08-09-2024 | 11-12-2024 | 03-28-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 2.054 M | 1.646 M | 2.132 M | 2.383 M | |
| Selling general and admin | 1.588 M | 1.080 M | 1.235 M | 1.064 M | |
| Research and development | 465.896 K | 566.335 K | 897.510 K | 1.319 M | |
| Total expenses | 2.054 M | 1.646 M | 2.132 M | 2.383 M | |
| -19.88% | 29.55% | 11.77% | |||
| Operating income | -2.054 M | -1.646 M | -2.132 M | -2.383 M | |
| Ebit | -2.055 M | -1.646 M | -2.132 M | -2.383 M | |
| Pretax income | -2.041 M | -1.646 M | -2.132 M | -2.369 M | |
| -19.35% | 29.55% | 11.10% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.041 M | -1.632 M | -2.132 M | -2.383 M | |
| 20.01% | -30.60% | -11.77% |
